Statement from Roche Canada re: Supply of Tamiflu(R) (oseltamivir)



    MISSISSAUGA, ON, April 29 /CNW/ - In light of recent global developments
about Swine Flu, and the World Health Organization's (WHO) decision to raise
the pandemic alert to phase 4, Roche Canada is diligently working with
Canada's federal and provincial governments to address their potential need
for additional supplies of Tamiflu.
    We are also working with Canadian hospitals to assess their needs for
Tamiflu.
    These ongoing discussions are intended to help us advocate for the needs
of Canadian governments and hospitals with our global manufacturing
colleagues, and will help us to continue to make every effort to satisfy
Canadian government and hospital requests for Tamiflu.
    While we understand there is increased public demand for the product,
Roche supports government's position on the appropriate use of anti-virals and
we remain focused on prioritizing government and hospital needs.
    For many years, Roche Canada has taken a proactive and responsible
approach in collaborating with government on their anti-viral stockpiling
activities. We will continue to proactively communicate with government and
hospitals.





For further information:

For further information: Samantha Ouimet, Roche Canada, (905) 542-5538,
samantha.ouimet@roche.com; Laura Pagnotta, Roche Canada, (905) 542-5853,
laura.pagnotta@roche.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890